Leadership Change - Incyte 任命 Bill Meury 为新 CEO，立即生效，接替退休的 Hervé Hoppenot [1] Stock Market Reaction - Incyte 股票周四上涨，原因在于 CEO 的变更 [1]

Stock Performance - Novo Nordisk's U.S-listed shares experienced a rise [1] Market Activity - An activist investor is reportedly building a stake in Novo Nordisk, the maker of Ozempic [1]